Pharmacokinetic studies of psilocybin in humans have shown the rapid dephos
phorylation of psilocybin to psilocin with further conversion to 4-hydroxy-
tryptophole (4HT) and 4-hydroxyindole-3-acetic acid (4HIAA) in plasma. Our
study shows that psilocin also undergoes conjugation and can be found in th
e urine as the psilocin-glucuronide conjugate. Recoveries after enzymatic h
ydrolysis of the urine with beta -glucuronidase (Helix Pomatia or E. Coli)
when compared to non-hydrolyzed urine confirmed the presence of the glucuro
nide. Detection of psilocin From hydrolyzed and extracted samples was optim
ized for GC/MS by derivatization with MSTFA. The method developed allows fo
r the detection of psilocin in urine with a limit of quantitation of 10 ng/
mL, based on 5 mt of spiked urine. Using this method, our laboratory has co
nfirmed the presence of psilocin in 6 out of 8 urine samples, with concentr
ations ranging from 10 ng/mL to greater than 200 ng/mL. Before implementati
on of the hydrolysis and derivatization steps, our limit of detection was 2
00 ng/mL, based on spiked urine standards. No case samples were positive wi
thout hydrolysis and derivatization.